RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+2.66%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$6.41B
AUM Growth
+$6.41B
(+7.5%)
Cap. Flow
+$866M
Cap. Flow
% of AUM
13.52%
Top 10 Holdings %
Top 10 Hldgs %
42.9%
Holding
120
New
18
Increased
32
Reduced
17
Closed
9
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$375M |
| 2 |
QuidelOrtho
QDEL
|
$112M |
| 3 |
ITOS
iTeos Therapeutics
ITOS
|
$57.7M |
| 4 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$51.7M |
| 5 |
PTC Therapeutics
PTCT
|
$50.8M |
Top Sells
| 1 |
Korro Bio
KRRO
|
$86.8M |
| 2 |
Rocket Pharmaceuticals
RCKT
|
$59.7M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$42.8M |
| 4 |
Penumbra
PEN
|
$20.7M |
| 5 |
Immunovant
IMVT
|
$19.8M |
Sector Composition
| 1 | Healthcare | 88.33% |
| 2 | Financials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Avidity Biosciences
RNA
$6.12B
| $87.1M | 1.36% |
3,995,000
| – | – |
|
27
Celldex Therapeutics
CLDX
$1.57B
| $80.5M | 1.26% |
3,908,947
+486,092
| +14% | +$10M |
|
28
C4 Therapeutics
CCCC
$182M
| $79.4M | 1.24% |
2,149,228
| – | – |
|
29
Tarsus Pharmaceuticals
TARS
$2.44B
| $79.1M | 1.23% |
2,463,601
| – | – |
|
30
Adverum Biotechnologies
ADVM
$68.2M
| $72.5M | 1.13% |
7,348,976
+121,612
| +2% | +$1.2M |
|
|
TBIO
31
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $72.3M | 1.13% |
4,382,199
+1,403,772
| +47% | +$23.1M |
|
32
MacroGenics
MGNX
$121M
| $64.2M | 1% |
2,014,400
+757,991
| +60% | +$24.1M |
|
33
IDEAYA Biosciences
IDYA
$2.26B
| $58M | 0.9% |
2,466,255
+619,412
| +34% | +$14.6M |
|
34
Castle Biosciences
CSTL
$673M
| $54.7M | 0.85% |
799,009
| – | – |
|
35
Relmada Therapeutics
RLMD
$48.8M
| $53.9M | 0.84% |
1,530,717
+18,044
| +1% | +$635K |
|
|
NSTG
36
DELISTED
NanoString Technologies, Inc.
NSTG
| $52.8M | 0.82% |
804,029
| – | – |
|
|
AVDL
37
Avadel Pharmaceuticals
AVDL
$1.42B
| $51.9M | 0.81% |
5,741,939
+354,426
| +7% | +$3.2M |
|
|
RXDX
38
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $51.7M | 0.81% |
+3,264,031
| New | +$51.7M |
|
39
Pulmonx
LUNG
$67.6M
| $51.7M | 0.81% |
1,129,600
| – | – |
|
40
Immunocore
IMCR
$1.78B
| $50.1M | 0.78% |
+1,245,532
| New | +$50.1M |
|
41
Athira Pharma
ATHA
$15.5M
| $48.8M | 0.76% |
2,652,553
-33,226
| -1% | -$611K |
|
42
Cytokinetics
CYTK
$5.98B
| $46.5M | 0.73% |
2,000,000
| – | – |
|
43
ProQR Therapeutics
PRQR
$256M
| $42.5M | 0.66% |
6,424,078
+1,414,310
| +28% | +$9.35M |
|
|
ISEE
44
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $41.5M | 0.65% |
6,722,624
| – | – |
|
45
Curis
CRIS
$21.5M
| $41M | 0.64% |
3,619,544
-107,816
| -3% | -$1.22M |
|
|
GTH
46
DELISTED
Genetron Holdings Limited ADS
GTH
| $39M | 0.61% |
+1,818,162
| New | +$39M |
|
|
LABP
47
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $38.3M | 0.6% |
+4,275,722
| New | +$38.3M |
|
48
Fulcrum Therapeutics
FULC
$353M
| $37.8M | 0.59% |
3,205,291
+1,133,882
| +55% | +$13.4M |
|
|
AGEN
49
Agenus
AGEN
$136M
| $37.5M | 0.59% |
13,777,244
+912,567
| +7% | +$2.48M |
|
50
Outset Medical
OM
$245M
| $37.4M | 0.58% |
687,152
+102,078
| +17% | +$5.55M |
|